This report provides insight into Bayer's digital technology activities, including its digital transformation strategies, its accelerator programs & innovation hubs, its technology initiatives, investment arm, investments, and its estimated ICT budget.
Bayer AG (Bayer) is a German life sciences company engaged in research, development, manufacture, and supply of healthcare and agriculture products. It is the parent company of the Bayer Group and performs the key management functions for the whole enterprise. The Bayer Group comprises three business divisions: Crop Science, Pharmaceuticals, and Consumer Health. The Pharmaceuticals division is engaged in manufacturing prescription medicines, particularly for cardiology and women's healthcare. It also produces specialty therapeutics for ophthalmology, hematology, oncology, cell and gene therapy. The division also has a radiology business which markets diagnostic imaging equipment and digital solutions. The consumer health division manufactures over-the-counter (OTC) medicines, nutritional supplements, medicated skincare products and self-care solutions for pain, allergy, cough, and digestive health. Meanwhile, the crop science division offers seeds, improved plant traits, biological and chemical crop protection products, and digital farming solutions. The company is using several emerging technologies such as AI, big data, and blockchain among others, running accelerator and incubator programs, and partnering or investing in digital companies to quickly develop new therapies.
Bayer AG (Bayer) is a German life sciences company engaged in research, development, manufacture, and supply of healthcare and agriculture products. It is the parent company of the Bayer Group and performs the key management functions for the whole enterprise. The Bayer Group comprises three business divisions: Crop Science, Pharmaceuticals, and Consumer Health. The Pharmaceuticals division is engaged in manufacturing prescription medicines, particularly for cardiology and women's healthcare. It also produces specialty therapeutics for ophthalmology, hematology, oncology, cell and gene therapy. The division also has a radiology business which markets diagnostic imaging equipment and digital solutions. The consumer health division manufactures over-the-counter (OTC) medicines, nutritional supplements, medicated skincare products and self-care solutions for pain, allergy, cough, and digestive health. Meanwhile, the crop science division offers seeds, improved plant traits, biological and chemical crop protection products, and digital farming solutions. The company is using several emerging technologies such as AI, big data, and blockchain among others, running accelerator and incubator programs, and partnering or investing in digital companies to quickly develop new therapies.
Scope
- The key technology themes under focus for Bayer are AI, big data, blockchain, wearable tech, cloud, virtual care & telemedicine, quantum computing, healthtech, and automation
Reasons to Buy
- Gain insights into Bayer's digital transformation strategies
- Gain insights into its technology themes under focus
- Gain insights into its various product launches, partnerships, and investments.
Table of Contents
- Overview
- Digital Transformation Strategy
- Accelerators, Incubators, and Other Innovation Programs
- Technology Focus
- Technology Initiatives
- Venture Arm: Leaps by Bayer
- Investment
- Acquisitions
- Partnership, Investment Acquisition Network Map
- ICT Budget and Contracts
- Key Executives
- Contact the Publisher
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ada Health
- One Drop
- Recursion Pharmaceuticals
- Blackford Analysis
- Exscientia
- Merck
- Cyclica
- Genpact
- Capgemini
- VeChain
- Veeva Systems
- Atos
- Pilloxa
- ABB
- Edifice Health
- Huma
- GRO Biosciences
